▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1434 by analyst upside · 2026-06-27
WEAV
Weave Communications, Inc.
Healthcare · Market Cap $471M · P/E 0x
ANALYST PRICE TARGET
+47.8%
implied upside to consensus target
Current Price $5.92
Consensus Target $8.75
Bull Target $9.0
Bear Target $8.0
Analysts Covering 4
ANALYST CONSENSUS — STRONG BUY
Strong Buy
2
Buy
2
Hold
0
Sell
0
52-Week Low $4.24
52-Week High $9.1
YTD Return -17.4%
FUNDAMENTALS
Market Cap $471M
P/E Ratio (TTM) N/A
Forward P/E 25.2x
EPS (TTM) $-0.35
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $249M
Profit Margin -10.1%
52-WEEK RANGE
52-Week Low $4.24
52-Week High $9.1
Current Price $5.92
Bear Target $8.0
Bull Target $9.0
● Now $5.92 ● Target $8.75
TRADING DATA
Avg Volume 1.3M
YTD Return -17.4%
Analyst Count 4
Consensus Strong Buy
Upside to Target +47.8%
Last Updated 2026-06-27

ANALYST SUMMARY

Weave Communications, Inc. (WEAV) is currently trading at $5.92 with a Wall Street consensus price target of $8.75, implying potential upside of 47.8% over the next 12 months. 4 analysts currently cover WEAV, with a consensus rating of Strong Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $9.0, while the most cautious has a target of $8.0.

WEAV operates in the Healthcare sector with a market capitalisation of $471M. The stock is down 17.4% year-to-date and is currently trading near the lower end of its 52-week range of $4.24 – $9.1.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AUNA +35.6%
Auna SA
$381M · P/E 18.4x · Buy
MDXG +65.4%
MiMedx Group, Inc.
$585M · P/E 19.6x · Buy
IRWD +47.7%
Ironwood Pharmaceuticals, Inc.
$680M · P/E 6.3x · Buy
BVS +51.3%
Bioventus Inc.
$663M · P/E 23.9x · Buy
KMDA +79.1%
Kamada Ltd.
$419M · P/E 20.7x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for WEAV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Stifel — Reiterated
Buy → Buy 2026-02-20 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2026-02-20 14% win rate (7 calls)
Citigroup — Reiterated
Neutral → Neutral 2025-11-03 Building track record
Stifel — Reiterated
Buy → Buy 2025-10-31 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2025-10-31 14% win rate (7 calls)
Stifel — Reiterated
Buy → Buy 2025-08-01 Building track record
Raymond James — Reiterated
Strong Buy → Strong Buy 2025-08-01 Building track record
Piper Sandler — Reiterated
Overweight → Overweight 2025-05-06 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →